Clinical Trial Update: Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of HL-1186 Tablet for moderate to severe acute postoperative pain; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• HL-1186 Tablet (HL-1186)

Snippet

Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | Conditions: Moderate to Severe Acute Postoperative Pain | Phase 2 | Status: RECRUITING